TRDA NASDAQ
Entrada Therapeutics, Inc.
1W: -7.6%
1M: -51.6%
3M: -44.1%
YTD: -37.2%
1Y: -23.4%
3Y: -51.8%
$6.56
+0.25 (+3.96%)
Weekly Expected Move ±30.2%
$3
$4
$6
$8
$10
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$6M
Revenue
-96.7% YoY
$-166M
Net Income
-770.3% YoY
$-132M
Free Cash Flow
-126.9% YoY
8.0%
Gross Margin
-4834.6%
Op. Margin
-4539.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-45.2%
ROA-36.8%
ROIC-229.7%
Valuation
P/E-1.7
P/B1.0
EV/EBITDA-1.7
Leverage
Debt/Equity0.17
Current Ratio12.53
Interest Cov.0.0x
Quality Scores
Piotroski F2/9
Altman Z2.84
Beneish M-2.50